Finance

Lists
Why is 20B down 3.27%?
Dive Deeper
20B:FRA
BioMark Diagnostics Inc
€0.30
-3.27%
(-0.0100) 1D
Oct 15, 8:06:27 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 20B...
Open
€0.30
High
€0.30
Low
€0.30
Mkt. cap
52.18M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.42
52-wk low
€0.15
Open
€0.30
High
€0.30
Low
€0.30
Mkt. cap
52.18M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.42
52-wk low
€0.15
News stories
From web sources and news partners
About BioMark Diagnostics Inc
CEO-
Employees-
Founded2014
HeadquartersRichmond, British Columbia, Canada
SectorBiotechnology
Websitebiomarkdiagnostics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.87K
6.92K
7.01K
7.01K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
190.09K
168.62K
196.56K
160.96K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
191.40K
191.88K
59.42K
160.10K
Operating expense
481.76K
526.42K
359.54K
421.17K
Total operating expenses
481.76K
526.42K
359.54K
421.17K
Operating income
-474.89K
-519.50K
-352.53K
-414.16K
Other non operating income
19.68K
163.16K
150.93K
54.55K
EBT including unusual items
-481.39K
-380.32K
-199.47K
-364.31K
EBT excluding unusual items
-481.39K
-380.32K
-199.47K
-364.31K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-481.39K
-380.32K
-199.47K
-364.31K
Net profit margin
-7,006.16%
-5,499.16%
-2,846.32%
-5,198.43%
Earnings per share
-
-
-
-
Interest and investment income
18.38K
16.22K
15.24K
5.48K
Interest expense
-6.39K
-22.71K
-25.01K
-23.29K
Net interest expenses
12.00K
-6.49K
-9.76K
-17.81K
Depreciation and amortization charges
86.50K
141.02K
54.31K
100.11K
EBITDA
-470.84K
-515.36K
-348.39K
-409.90K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps